AI assistant
Sending…
BICYCLE THERAPEUTICS PLC — Director's Dealing 2021
Sep 3, 2021
32777_dirs_2021-09-03_c77a3950-ec5c-4bd2-9a62-375906b2f7f5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BICYCLE THERAPEUTICS plc (BCYC)
CIK: 0001761612
Period of Report: 2021-09-02
Reporting Person: Kalowski Lee (President and CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-09-02 | Ordinary Shares | M | 10000 | $9.82 | Acquired | 10000 | Direct |
| 2021-09-02 | Ordinary Shares | S | 10000 | $40.00 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-09-02 | Employee Stock Option (right to buy) | $9.82 | M | 10000 | Disposed | 2030-01-02 | Ordinary Shares (10000) | Direct |
Footnotes
F1: Shares exercised and sold pursuant to a Rule 10b5-1 trading plan.
F2: This option shall vest one-fourth (1/4) of the total number of shares under option on January 2, 2021 and the remaining shares in 36 equal monthly installments at the end of each calendar month thereafter.
More from BICYCLE THERAPEUTICS PLC
Regulatory Filings
2026
May 21
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 20
Director's Dealing
2026
Mar 25
Annual Report
2026
Mar 17
Regulatory Filings
2026
Mar 17
Major Shareholding Notification
2026
Feb 11
Director's Dealing
2026
Feb 4
Regulatory Filings
2026
Feb 3